Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. JYNT
JYNT logo

JYNT Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Joint Corp (JYNT) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
9.340
1 Day change
2.41%
52 Week Range
13.000
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Joint Corp (JYNT) is not a strong buy at the moment for a beginner investor with a long-term horizon. While insider buying is a positive signal, the lack of strong upward momentum, absence of significant trading signals, and potential for short-term price declines suggest waiting for a better entry point. The technical indicators are neutral, and there are no recent news catalysts or financial data to support a compelling buy case.

Technical Analysis

The MACD is positive and expanding, which is a bullish signal. However, the RSI is neutral at 65.22, and moving averages are converging, indicating no clear trend. The stock is trading near its resistance level (R1: 9.502), which might limit further upside in the short term.

Options Data

Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
1
Buy
10

Positive Catalysts

  • Insiders are buying significantly, with a 24955.71% increase in buying activity over the last month.

Neutral/Negative Catalysts

  • No recent news or event-driven catalysts. Stock trend analysis suggests a 70% chance of short-term declines (-1.35% in the next day, -2.69% in the next week, -6.23% in the next month).

Financial Performance

No financial data available for analysis.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No data on analyst ratings or price target changes.

Wall Street analysts forecast JYNT stock price to rise
5 Analyst Rating
Wall Street analysts forecast JYNT stock price to rise
2 Buy
3 Hold
0 Sell
Moderate Buy
Current: 9.120
sliders
Low
9
Averages
11.33
High
14
Current: 9.120
sliders
Low
9
Averages
11.33
High
14
Roth Capital
Buy
downgrade
$14 -> $12
AI Analysis
2026-03-13
Reason
Roth Capital
Price Target
$14 -> $12
AI Analysis
2026-03-13
downgrade
Buy
Reason
Roth Capital lowered the firm's price target on Joint Corp. to $12 from $14 and keeps a Buy rating on the shares. The company's Q4 results exceeded estimates while its 2026 guidance largely mirrors the firm's model, the analyst tells investors in a research note. Roth adds, however, that the management's post-refranchising pro forma model is "underwhelming", even though it continues to see significant long-term upside.
B. Riley
B. Riley
Buy -> Neutral
downgrade
$18 -> $9
2025-11-07
Reason
B. Riley
B. Riley
Price Target
$18 -> $9
2025-11-07
downgrade
Buy -> Neutral
Reason
B. Riley downgraded Joint Corp. to Neutral from Buy with a price target of $9, down from $18. The company's Q3 comps were down 2.0%, reflecting continued softness in new patient acquisition, the analyst tells investors in a research note. The firm Joint's fiscal 2025 as "transitional," as the company tests initiatives and completes refranchising. It cites deteriorating trends for the downgrade.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for JYNT
Unlock Now

People Also Watch